Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 May 1;22(9):2255-63.
doi: 10.1093/emboj/cdg206.

Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse

Affiliations

Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse

Josiane Ménissier de Murcia et al. EMBO J. .

Abstract

The DNA damage-dependent poly(ADP-ribose) polymerases, PARP-1 and PARP-2, homo- and heterodimerize and are both involved in the base excision repair (BER) pathway. Here, we report that mice carrying a targeted disruption of the PARP-2 gene are sensitive to ionizing radiation. Following alkylating agent treatment, parp-2(-/-)-derived mouse embryonic fibroblasts exhibit increased post-replicative genomic instability, G(2)/M accumulation and chromosome mis-segregation accompanying kinetochore defects. Moreover, parp-1(-/-)parp-2(-/-) double mutant mice are not viable and die at the onset of gastrulation, demonstrating that the expression of both PARP-1 and PARP-2 and/or DNA-dependent poly(ADP-ribosyl) ation is essential during early embryogenesis. Interestingly, specific female embryonic lethality is observed in parp-1(+/-)parp-2(-/-) mutants at E9.5. Meta phase analyses of E8.5 embryonic fibroblasts highlight a specific instability of the X chromosome in those females, but not in males. Together, these results support the notion that PARP-1 and PARP-2 possess both overlapping and non-redundant functions in the maintenance of genomic stability.

PubMed Disclaimer

Figures

None
Fig. 1. Targeted disruption of parp-2. (A) Map of the parp-2 murine genomic locus and targeting vector. Exons are indicated by black boxes and the position of the external probe is represented by a gray box. The PGK-hygromycin cassette is inserted in the opposite transcriptional orientation and replaces a BamHI (B) fragment of exon 9 and intron 10. (B) Representative genomic blot probed with the external probe. A wild-type 4.5 kb and a recombined 3.7 kb fragment are shown. Mice were identified as wild-type (+/+), heterozygous (+/–) or homozygous mutant (–/–). (C) PARP-2 is not expressed in cells isolated from the testis of parp-2–/– mice. (D) Northern blot analysis of total RNA from testis using a 820 bp EcoRI fragment of parp-2 cDNA as a probe. Note that the expression of the RNase P RNA is not influenced by the parp-2 disruption.
None
Fig. 2. parp-2–/– mice are sensitive to ionizing radiation. (A) Kaplan–Meier survival curve after 8 Gy of irradiation. Wilcoxon test: P (parp-2+/+ versus parp-2–/–) < 10–5; P (parp-2–/– versus parp-2+/–) < 0.002. (B) Stained transverse sections of the duodenum from a parp-2+/+ and a parp-2–/– mouse 6 days after a dose of 8 Gy was given. Lumen (l), villi (v). (C) Mean number of chromatid breaks in bone marrow cells taken from mock-irradiated mice or 7 h after 2 Gy whole-body irradiation. (D) Occurrence of chromatid breaks in the centromeric region 7 h after 2 Gy irradiation. (E) Metaphase spreads of bone marrow cells from irradiated parp-2+/+ and parp-2–/– mice. Chromatid break in the centromeric region (top arrow) and tetraradian in metaphase (bottom arrow) from an irradiated parp-2–/– mouse. Magnifications are details pointed to by arrows.
None
Fig. 3. (A) Sister chromatid exchanges in bone marrow cells from parp-2+/+ and parp-2–/– mice 9 h after i.p injection with (50 mg/kg) MNU. (B) Cell cycle profile analyzed after propidium iodide staining of parp-2+/+ and parp-2–/– MEFs at passage 2, 24 h following 2 mM MNU treatment. The percentage of cells containing (2N) (4N) and (8N) is indicated. (C) Quantitative analysis of chromosome mis-segregation in parp-2+/+ and parp-2–/– MEFs at passage 2, 24 h following 2 mM MNU treatment. The fraction of mitotic cells that exhibited a defect in segregation, such as lagging chromosomes (see D, panels d–f), is shown. (D) Anaphases in parp-2+/+ and parp-2–/– MEFs following 2 mM MNU treatment. Kinetochores (green) are immunostained with the CREST serum (a and d). Lagging chromosomes forming an anaphase bridge indicated by arrows in parp-2–/– cells. Bars indicate 10 µm.
None
Fig. 4. (A) Fluorescent TUNEL stain of thymus 2 days after 6 Gy irradiation. Apoptotic cells are labeled in green, and cell nuclei are stained with DAPI. parp +/+ are sparsely stained whereas parp-1–/– and parp-2–/– show a strong green staining of apoptotic cells. (B) PARP-1 and PARP-2 cleavage kinetics after 100 µM VP16 treatment in HL-60 cells. Z-VAD-fmk inhibitor was used at 0.5 µg/µl and was added 1 h before VP16 treatment. For western blot, 105 cells were harvested at the indicated time, mixed with loading buffer and sonicated. Polyclonal antibodies anti-PARP-1 and anti-PARP-2 were used. (CIn vitro cleavage of purified mPARP-2 (2.5 µg) by active caspase-3 (8 U, Chemicon International) shows the same cleavage pattern in HL-60 cells after VP-16 treatment. The N-terminus of the 55 kDa band was micro sequenced and was found to be 58DNRD61, a consensus cleavage site for caspases 3/7.
None
Fig. 5. External views of E8.0–8.5 (A–C) and E11.5 (D) embryos. (A) A normal parp-1+/–parp-2–/– embryo. (B and C) Retarded parp-1–/– parp-2–/– embryos. (D) Example of two parp-1+/–parp-2–/– female embryos that are phenotypically arrested at E9.5, and one normal parp-1+/–parp-2+/– female embryo at E11.5. The same magnifications were used in (A), (B) and (C).
None
Fig. 6. parp-1+/–parp-2–/– females display X-chromosome instability. X chromosomes are stained in pink (rhodamine), and chromosomes are counterstained in blue (DAPI). Examples of metaphases with various numbers of X chromosomes in parp-1+/–parp-2–/– females: (A) 2X; (B) 1X; (C) 2X + derX.

References

    1. Allen J.W., Shuler,C.F., Mendes,R.W. and Latt,S.A. (1977) A simplified technique for in vivo analysis of sister-chromatid exchanges using 5-bromodeoxyuridine tablets. Cytogenet. Cell Genet., 18, 231–237. - PubMed
    1. Amé J.C. et al. (1999) PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem., 274, 17860–17868. - PubMed
    1. Amé J.C., Schreiber,V., Fraulob,V., Dollé,P., de Murcia,G. and Niedergang,C.P. (2001) A bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA. Structure and expression of the mouse PARP-2 gene. J. Biol. Chem., 276, 11092–11099. - PubMed
    1. Avner P. and Heard,E. (2001) X-chromosome inactivation: counting, choice and initiation. Nat. Rev. Genet., 2, 59–67. - PubMed
    1. Benchoua A., Couriaud,C., Guegan,C., Tartier,L., Couvert,P., Friocourt,G., Chelly,J., Menissier-de Murcia,J. and Onteniente,B. (2002) Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J. Biol. Chem., 277, 34217–34222. - PubMed

Publication types